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1. Introduction 
Neurodegenerative diseases comprise of a large group of pathologies that affect a 
considerable number of individuals among the world’s population with a higher incidence 
in elderly people. The most common neurodegenerative diseases, such as Alzheimer’s 
disease (AD) and Parkinson’s disease (PD), are characterised by the presence of protein 
aggregates in different regions of the brain. The causes of these diseases remain 
undetermined. Nevertheless, new information on this topic is continuously being brought to 
light. 
Mitochondrial dysfunction has been implicated in the pathogenesis of PD. The first evidence 
for this came from studies using the neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine) and the complex I inhibitor rotenone, which cause parkinsonism in 
animal models, making them a useful system for investigating the mechanisms underlying 
PD. The subsequent discovery of several gene mutations responsible for causing heritable 
forms of PD that are directly linked to mitochondria (either genes encoding proteins that are 
localised to mitochondria (PINK1) or have some role in mitochondrial function (parkin, DJ-
1)) provided further insights into the importance of mitochondria in the pathogenesis of PD. 
More recently, some of the gene products of PARK loci have been found to participate in 
mitochondrial quality control systems. In this review, we describe, in detail the molecular 
mechanism of mitochondrial quality control as well as the importance of a mitochondrial 
unfolded protein response and its possible relevance to the symptoms of PD. 
2. Mitochondria: Essential organelles of eukaryotic cells 
Mitochondria are cellular organelles with a multitude of functions, ranging from the 
production of the majority of ATP in the cell, storage of calcium and buffering of its 
cytosolic concentration to participation in different pathways that influence cellular 
homeostasis and fate, including cell death cascades. 
Mitochondria are two-membrane organelles with an outer membrane facing the cytosol and 
an inner membrane facing the mitochondrial matrix; the space between the membranes is 
referred to as the inter-membrane space (IMS). Both the outer and inner membranes are 
composed of phospholipids and proteins; however, they have different properties. The 
outer membrane is highly permeable to small molecules due to the presence of porins 
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within its structure, which allows the IMS to maintain approximately the same 
concentrations of ions and sugars as the cytosol. However, the inner membrane does not 
exhibit such permeability, thus the passage of molecules to the matrix is highly selective. 
Most IMS proteins have well-characterised roles in apoptosis following release from the 
mitochondria into the cytosol, such as cytochrome c, Smac/DIABLO, HtrA2/Omi, and 
endonuclease G (Endo G) (Radke et al., 2008). 
The inner mitochondrial membrane exhibits a particular organisation including several 
invaginations that form the mitochondrial cristae. This organisation makes the length of the 
membrane much greater and enables a higher efficiency of energy production. It is in the 
inner membrane of the mitochondria where the electron transport chain (ETC) is located. 
The ETC is comprised of five protein complexes and is responsible for the oxidative 
phosphorylation (OXPHOS) that results in the production of energy in the form of 
adenosine triphosphate (ATP), which is accompanied by consumption of oxygen and 
production of water. Complexes I, III and IV pump protons (H+) into the IMS and create a 
gradient essential for the generation of ATP by complex V (ATP synthase). This proton 
gradient is crucial for the normal functioning of mitochondria and is known as the 
mitochondrial membrane potential (m). Reactive oxygen species (ROS) are also 
generated as a by-product of OXPHOS. ROS production can be partially modulated by two 
cofactors, coenzyme Q10 at complex III and cytochrome c at complex IV (Mattson et al., 
2008).  
The mitochondrial matrix is a sub-compartment with a high protein content. It contains all 
of the enzymes required for the Krebs cycle, fatty acid oxidation and haeme synthesis and 
also incorporates several chaperones and proteases involved in the folding and degradation 
of proteins. In addition, the matrix contains mitochondrial DNA (mtDNA), together with 
the proteins required for its transcription and translation. Although most mitochondrial 
proteins (1500) are encoded by nuclear DNA, thirteen proteins involved in the ETC are 
mitochondrially encoded (Ryan and Hoogenraad, 2007). This constitutes a challenge for the 
cell as both nuclear and mitochondrial transcription must be tightly coordinated. Due to its 
localisation near the ETC, mtDNA is susceptible to oxidative damage, which may result in 
mutations. 
The number of mitochondria is variable according to the tissue and cell type, and it reflects 
the energetic needs of the cell. For example, neurons and muscle cells have a high 
mitochondrial content compared to other cell types. The number of mitochondria can be 
modulated, but these organelles cannot be generated de novo. Mitochondrial biogenesis 
consists of an increase in the translation of mitochondrial proteins (both nuclearly and 
mitochondrially encoded); recruitment of these proteins to the mitochondria, which results 
in mitochondrial enlargement; and finally, division and generation of additional 
mitochondrion units (Ryan and Hoogenraad, 2007). Within a cell, a mitochondrion cannot 
be considered as an individual and independent organelle. Mitochondria behave as a 
network exhibiting successive cycles of fusion (mitochondrion units combining with each 
other) and fission (separation of mitochondrion units). Mitochondrial dynamics make these 
organelles more capable of responding to different cellular demands. The proteins 
responsible for mitochondrial dynamics are relatively well characterised, although new 
proteins are constantly being identified that play roles in this active process. 
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Due to the importance of mitochondria for cellular homeostasis, it is obvious that the 
dysfunction of this organelle may result in severe consequences. Depending on the extent of 
damage, different signalling pathways will be activated. If the extent of damage is too 
severe, it might cause dissipation of the mitochondrial membrane potential and release of 
pro-apoptotic proteins (such as cytochrome c and HtrA2), resulting in cell death. 
Mitochondrial dysfunction has long been associated with the natural chronic process of 
ageing as well as with neurodegenerative diseases, such as AD and PD, and metabolic 
diseases, such as diabetes. Neurons are particularly sensitive to mitochondrial dysfunction, 
which probably reflects their high energetic needs and their absolute dependence on 
mitochondria to obtain most of the ATP required for neuronal function (de Castro et al., 
2010). The presence of protein aggregates is also a characteristic of the neurodegenerative 
diseases PD and AD. The importance of proper protein folding has long been recognised, 
and the effects of un-/misfolding and aggregation have been linked to many pathological 
conditions. These aggregates may be cytosolic, such as Lewy bodies in PD and fibrillary 
tangles in AD, or extracellular, such as amyloid plaques in AD. However, little is known 
about the effects of unfolded proteins in the mitochondria. 
Protein homeostasis is important to maintain cells in a healthy state; therefore, it is essential 
to prevent the accumulation of proteins in non-native forms. A recent study in the nematode 
C. elegans has shown that in this multicellular animal, a considerable number of proteins 
aggregate with age (David et al., 2010). These aggregation-prone proteins may also be 
related to the deregulation of proteostasis in some neurodegenerative diseases. A better 
understanding of the mechanisms involved in protein misfolding and aggregation will 
certainly help to explain the causes and/or progression of certain diseases. 
3. Concepts of mitochondrial quality control 
As mentioned above, oxidative damage is likely to occur in mitochondria (the main ROS 
source), possibly affecting proteins, lipids and mtDNA. Multiple quality control systems 
exist to protect mitochondria and ultimately, the cell against damage (Figure 1). Primarily, 
as part of a molecular quality control system within the organelle, mitochondrial chaperones 
and proteases play roles in the processes of protein folding, the assembly of protein 
complexes and the degradation of misfolded or damaged proteins. Second, at the organellar 
level, there is another mechanism of quality control that depends on the dynamic nature of 
mitochondrial fusion and fission events (Tatsuta and Langer, 2008). When fusing with 
healthy mitochondria, damaged mitochondria can recover by sharing essential solutes, 
metabolites and other components from the healthy partner. However, if the damage is too 
severe, mitochondria will not undergo fusion but instead will lose their mitochondrial 
membrane potential and be eliminated by autophagy, a process also known as mitophagy. 
Finally, under sufficiently severe damage, cellular quality control mechanisms can be 
activated. In this case, upon the opening of the mitochondrial permeability transition pore 
(mPTP) and release of pro-apoptotic proteins from the IMS, the cell may undergo apoptosis. 
The focus of this review will be on the molecular quality control of mitochondria because 
both the organellar and cellular aspects of mitochondrial quality control have been 
extensively reviewed (de Castro et al., 2010, Knott and Bossy-Wetzel, 2008, Tatton et al., 
2003). 
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Fig. 1. Mitochondrial Quality Control is assured by different mechanisms and effectors; at 
the molecular level, it is assured through the protective action of chaperones and proteases, 
such as molecular chaperones in the mitochondrial matrix, AAA-proteases in the inner 
membrane, and HtrA2 and TRAP1 in the IMS (drawing highlighted in blue). When this 
mechanism of defence is not sufficient to maintain fully functional mitochondria, a second 
level of quality control exists at the organellar level. Fusion with healthy mitochondria 
might be sufficient to restore the functionality of a mitochondrion. Otherwise, fission might 
occur, producing small mitochondria that will not fuse again but will be degraded by 
autophagy (mitophagy) (highlighted in green). If the damage to the mitochondria is too 
severe, it might lead to the opening of the mitochondrial permeability transition pore 
(mPTP), releasing pro-apoptotic proteins into the cytosol, such as cytochrome c and HtrA2, 
resulting in the activation of apoptosis (drawing highlighted in red). 
3.1 Effectors of molecular quality control: Chaperones and proteases 
Molecular chaperones play critical roles in the maintenance of protein homeostasis by 
aiding in the folding of newly synthesised and/or imported proteins, the assembly of 
multimeric protein complexes, protein translocation across membranes and protein 
degradation. In addition, molecular chaperones are essential for cellular signalling. In 
eukaryotes, chaperones are segregated to specific places, such as the cytosol, endoplasmic 
reticulum (ER) and mitochondria. The mechanisms through which the levels of chaperones 
are modulated have not been well studied. Nevertheless, it is known that signalling 
pathways activating chaperone-encoding genes are repressed by free chaperones that are 
not engaged by client proteins (Yoneda et al., 2004). In contrast, if the levels of client proteins 
are too high, the availability of free chaperones can be dramatically decreased, and the 
repressor effect will not occur, possibly resulting in increased transcription of chaperones. 
The mitochondrial chaperones and proteases are essential components of the mitochondrial 
quality control mechanism because they selectively remove unfolded or misfolded proteins, 
avoiding their deleterious accumulation. A failure in molecular quality control is emerging 
as a feature of neurodegenerative diseases, such as PD. 
www.intechopen.com
 
Emerging Concepts Linking Mitochondrial Stress Signalling and Parkinson’s Disease 
 
81 
3.1.1 AAA protease chaperones 
ATP-dependent proteases are present in the mitochondrial matrix as well as in the inner 
membrane. The AAA+ (ATPases associated with various cellular activities) superfamily of 
peptidases is able to eliminate misfolded proteins from the mitochondria and plays a 
regulatory role during mitochondrial biogenesis by processing proteins. Mammalian inner 
mitochondrial membranes possess hetero- and homo-oligomeric m-AAA and homo-
oligomeric i-AAA protease complexes. The m-AAA protease presents its catalytic site on the 
mitochondrial matrix, while the i-AAA protease catalytic site is directed to the IMS. The 
homo-oligomeric complexes are composed of AFG3L2 subunits, while the hetero-oligomeric 
are composed of paraplegin and AFG3L2 subunits. Mutations in these proteases have been 
implicated in neurodegenerative conditions; mutations in the paraplegin subunit cause 
hereditary spastic paraplegia which is characterised by cell-specific axonal degeneration, 
and mutations in AFG3L2 lead to a dominant heritable form of spinocerebellar ataxia (Lee et 
al., 2011). Furthermore, a mutation in the mitochondrial chaperone Hsp60 has also been 
identified in hereditary spastic paraplegia. The mitochondrial matrix chaperone Hsp60 
mediates ATP-dependent folding of a wide variety of proteins, making it an important 
player in the molecular mitochondrial quality control system. 
3.1.2 PINK1, HtrA2 and TRAP1 
The mitochondrial protein PTEN-induced putative kinase 1 (PINK1) plays important roles 
in mitochondrial quality control. It participates in molecular quality control through 
interactions with high-temperature-requirement protein A2 (HtrA2) and possibly TNF 
receptor–associated protein 1 (TRAP1) and at the organellar level via its activity in a 
signalling pathway involving parkin and mitophagy. The PINK1 and PARK13 (HtrA2) genes 
have been found to be associated with PD. Mutations in PINK1 cause an autosomal recessive 
form of the disease, which can be characterised by early onset (Valente et al., 2004). 
Additionally, mutations in the HtrA2 gene have been found in sporadic PD patients, and 
HtrA2 protein has been detected in Lewy bodies (Strauss et al., 2005). Furthermore, an 
increase in phosphorylated HtrA2 in brain tissues of sporadic PD patients and, conversely, 
reduced phosphorylation in PD patients with PINK1 mutations have also been reported 
(Plun-Favreau et al., 2007).  
3.1.2.1 HtrA2 
HtrA2 (also known as Omi) was first identified as a mammalian homologue of the bacterial 
endoprotease HtrA (high temperature requirement A). In bacteria, HtrA acts as a chaperone 
at normal temperatures and as a protease at high temperatures and removes damaged or 
denatured proteins from the periplasm (Faccio et al., 2000). HtrA2 is a serine protease with 
an amino-terminal inhibitor of apoptosis (IAP) domain identical to those in the Drosophila 
protein Reaper. It is localised in the IMS, and following certain stimuli, it is released into the 
cytosol, where it binds to IAPs, inhibiting their effects and promoting apoptosis. In addition 
to its caspase-dependent action, HtrA2 promotes cell death in a caspase-independent 
manner through increased proteolytic activity (Martins et al., 2003). HtrA2 was initially 
thought to be a pro-apoptotic protein homologous to Reaper. However, the observation that 
HtrA2-mutant mice present an extremely shortened lifespan (~30 days) and a neurological 
phenotype with parkinsonian features has promoted a different view of the role of this 
protein (Martins et al., 2004).  
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The phosphorylation state of HtrA2 influences its proteolytic activity and is dependent on 
PINK1 (Plun-Favreau et al., 2007). PINK1 and HtrA2 interact with each other, although it is 
not clear whether PINK1 phosphorylates HtrA2. Nevertheless, phosphorylation of HtrA2 
occurs upon p38 MAPK activation and requires PINK1. It appears that p38, PINK1 and 
HtrA2 are components of a stress-sensing pathway and that phosphorylation of HtrA2 
increases its proteolytic activity and enhances its cell-protective effects. The observation that 
higher levels of phosphorylated HtrA2 are present in the brains of sporadic PD patients has 
led to the hypothesis that this stress-sensing pathway is activated in PD. However, the 
precise stimulus that originates the stress is not known. Interestingly, in brains from PD 
patients with PINK1 mutations, the levels of phosphorylated HtrA2 are reduced, 
emphasising the importance of PINK1 for HtrA2 phosphorylation. This reduced HtrA2 
phosphorylation might account for the pathogenic effects of PD-linked PINK1 mutations. 
Thus, HtrA2 appears to be part of a quality control pathway, acting downstream of PINK1.  
HtrA2 knockout (KO) mice show accumulation of unfolded proteins in the mitochondria as 
well as a defect in respiration. Loss of HtrA2 augments ROS levels, and treatment with anti-
oxidants is neuroprotective in this condition. The up-regulation of the transcription factor 
C/EBP homology protein (CHOP) specifically in the brain of the HtrA2 KO mice indicates 
activation of the integrated stress response. Enhanced levels of CHOP have also been 
detected in brain tissue of idiopathic PD patients (Moisoi et al., 2009). This increased level of 
CHOP specifically in the brain may account for the neuronal loss observed in this mouse 
model. However, the observation that CHOP is also up-regulated in regions of the brain that 
do not undergo neuronal death indicates that CHOP up-regulation is an early event that 
precedes neuronal loss. 
HtrA2 also interacts with both intracellular amyloid  (A) and the C-terminal tail of 
presenilins, although the functional significance of these interactions is obscure (Gupta et al., 
2004, Park et al., 2004). More recently, HtrA2 has been linked to amyloid precursor protein 
(APP) metabolism (Huttunen et al., 2007). A small percentage of HtrA2 localises alongside 
ER membranes and binds to immature APP in vitro. Finally, in HtrA2-/- cells, APP is 
stabilised, and A production is increased. These observations further suggest that HtrA2 
has a protective effect and functions in protein homeostasis. 
3.1.2.2 TRAP1 
Another piece of evidence relating PINK1 to mitochondrial molecular quality control comes 
from an in vitro study that revealed a physical interaction between PINK1 and the 
mitochondrial chaperone TRAP1 (Hsp75) (Pridgeon et al., 2007). PINK1 phosphorylates 
TRAP1 (also located in the IMS), and this protects the cell against apoptosis induced by 
H2O2 treatment. Notably, the PINK1-dependent phosphorylation of TRAP1 inhibits the 
release of cytochrome c from mitochondria and thereby increases cell survival under certain 
stress conditions (Pridgeon et al., 2007). TRAP1 may therefore be another downstream 
effector of PINK1 involved in the molecular mitochondrial quality control pathway. TRAP1 
is structurally related to the HSP90 family, possesses an ATP-binding domain and shows 
ATPase activity in vitro. TRAP1 activity can be inhibited by the Hsp90 inhibitors radicicol 
and geldanamycin. Nevertheless, TRAP1 does not form complexes with the classic co-
chaperones of Hsp90 and might have distinct functions from the other members of the 
HSP90 family (Felts et al., 2000). In addition, TRAP1 exerts a protective effect against 
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apoptosis when cells are subjected to various apoptotic stimuli (Hua et al., 2007, Masuda et 
al., 2004). Moreover, high levels of TRAP1 protein may be involved in drug resistance in 
certain cancer treatments (Costantino et al., 2009, Landriscina et al., 2010). More detailed 
studies are necessary to better understand the roles of TRAP1 in mitochondrial quality 
control and possibly in other signalling pathways. 
It is clear that maintenance of proteostasis is crucial for the health of the cell, and it is logical 
to hypothesise that regulation of quality control mechanisms must be of great importance 
when an insult occurs. As mentioned above, the various sub-compartments of the cell 
exhibit different subsets of chaperones and proteases that have location-specific functions. 
Accordingly, depending on the insult and the organelles affected, different stress responses 
might be activated.  
3.2 A mitochondrial unfolded protein response (UPR
mt
) with its origin in the 
mitochondrial matrix 
The concept of anterograde communication between the nucleus and mitochondria is well 
established; however, the communication process from the mitochondria to the cytosol and 
nucleus, so-called retrograde signalling, remains unclear. The main problem in 
understanding this process lies in identification of the molecules responsible for the 
initiation of the signal in the mitochondria and determination of how this signal is 
transmitted to the nucleus to alter nuclear gene expression. The mitochondrial retrograde 
signalling pathway is associated with both normal and pathophysiological conditions. This 
retrograde signalling pathway exists in simple organisms, such as yeast, where it has 
primarily been studied, and in multicellular organisms. Despite the fact that this signalling 
pathway is conserved, the proteins and molecular mechanisms involved do not seem to be. 
Compartment specificity in signalling by chaperones has been demonstrated for the ER, the 
cytoplasm and the mitochondrial matrix. These compartment-specific signals are responses 
to the presence of unfolded proteins in each of these compartments. Following the 
accumulation of unfolded proteins in the cytosol, heat shock–sensitive transcription factors 
(HSFs) are activated and increase the transcription of proteins involved in adaptation to this 
stress, a process known as the heat-shock response (HSR). The signal derived from an excess 
of unfolded proteins in the ER, on the other hand, is sensed by the lumenal domains of 
transmembrane proteins and is propagated through their cytoplasmic domains, ultimately 
leading to the transcription of nuclear genes encoding proteins that alleviate the stress in the 
ER (e.g., the ER chaperone BiP). This process is known as the unfolded protein response of 
the ER (UPRER) (Benedetti et al., 2006).  
The stress responses can also be induced by drug treatments. For example, treatment of cells 
with arsenite, which results in the accumulation of unfolded proteins in the cytoplasm, 
selectively activates cytoplasmic chaperone gene expression. On the other hand, treatment 
of cells with tunicamycin, which blocks ER-specific N-linked glycosylation, activates the 
UPRER, resulting in increased expression of ER-localised chaperones (Yoneda et al., 2004). 
Remarkably, little is known about the specific stress response resulting from the 
accumulation of unfolded proteins in the mitochondria, despite the fact that many different 
model systems have been used to study it. Here, we describe recent findings achieved in C. 
elegans and, to a lesser extent, mammalian model systems in detail. 
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3.2.1 C. elegans 
The nematode C. elegans has been extensively used to study the UPRmt. The ability to use 
sensitive reporter genes as well as the ease of genetically manipulating these worms makes 
them convenient models to address this issue. The existence of a UPRmt in C. elegans became 
evident after it was observed that provoking stress in the mitochondrial matrix, either by 
reduction of mtDNA through treatment with ethidium bromide or down-regulation of 
mitochondrial chaperones or proteases (spg-7), resulted in transcriptional up-regulation of 
the mitochondrial chaperones hsp-6 (the C. elegans orthologue of human mtHsp70) and hsp-
60 (Yoneda et al., 2004). Up-regulation is a specific response for these stress modulator 
molecules, as the cytosolic or ER chaperones are not up-regulated nor are other 
mitochondrial enzymes. Further studies using RNAi library screening led to the discovery 
of several genes required for UPRmt signalling (Figure 2).  
 
Fig. 2. Mitochondrial stress signalling 
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Key components of the molecular quality control machinery and mitochondrial unfolded 
protein response (UPRmt) are represented here. Communication between mitochondria and 
the nucleus is tightly regulated. Retrograde signalling transmits information from the 
mitochondria to the nucleus (dashed lines), whereas anterograde signalling transmits 
information in the opposite direction (solid lines). The mechanism of UPRmt activation in the 
nematode C. elegans is highlighted in green on the left. In C. elegans, the accumulation of 
unfolded proteins in the mitochondrial matrix may be sensed by the ClpXP complex, which 
might generate a signal leading to certain nuclear events. The nature of this signal remains 
elusive, although ClpXP activity is known to result in the formation of small peptides that 
are actively extruded to the IMS through the peptide transporter HAF-1. Once in the IMS, 
the peptides can be released to the cytosol and activate a receptor or other effector 
molecules. The bZIP transcription factor ZC3376.7 is activated by this peptide efflux from 
mitochondria and translocates to the nucleus, where it up-regulates UPRmt-responsive 
genes. Nuclear events occur on UPRmt include the transcriptional up-regulation of ubl-5 and 
redistribution of DVE-1 in the nucleus. While both events are downstream of ClpXP, only 
ubl-5 transcription activation is downstream of HAF-1. This UPRmt activation results in 
increased levels of both hsp60 and hsp6 mitochondrial chaperones. The mechanism of 
UPRmt activation in mammalian cells is highlighted in blue on the right. The presence of 
excess unfolded proteins in the mitochondrial matrix promotes transcriptional up-
regulation of Chop and formation of a complex between the transcription factor CHOP and 
C/EBPǃ in the nucleus, resulting in transcriptional activation of mitochondrial stress 
responsive genes, such as Hsp60, Hsp10, ClpP and mtDnaJ and increased levels of their 
encoded proteins in the mitochondria. HtrA2 is located in the IMS and is part of the protein 
quality control machinery. The proteolytic activity of HtrA2 is phosphorylation-dependent, 
requires the presence of PINK1 and is mediated through p38 pathway activation. The 
molecular chaperone TRAP1 is also located in the IMS and might be responsible for the 
proper folding and assembly of other proteins or complexes. TRAP1 also has a 
cytoprotective effect in inhibiting the release of cytochrome c when there is an increase level 
of ROS in mitochondrial. The unfolded protein response of the IMS is represented in the 
upper middle part of the mitochondria in the figure. This stress response can be activated on 
accumulation of aggregates of misfolded proteins in the IMS, which can be a result of failure 
of the proteasome, or due to failure of the molecular quality control in this compartment. 
The presence of protein aggregates leads to overproduction of ROS, activation of AKT and 
phosphorylation of the Estrogen Receptor ǂ (ERǂ). Activation of ERǂ receptor results in 
transcription of genes, such as transcription factor NRF1, proteasome and HtrA2. 
Ubiquitin-like protein 5 (UBL-5) is essential for UPRmt activation, although its down-
regulation does not result in the accumulation of misfolded proteins in the mitochondria, 
suggesting that it must act downstream of this event. Moreover, upon mitochondrial stress, 
ubl-5 is transcriptionally up-regulated, and its protein levels are increased in the nucleus 
(Benedetti et al., 2006). This might be a feed-forward mechanism to amplify the stress 
response. It is of note that UBL-5 mRNA levels are reasonably high in mitochondrion-rich 
human tissues, such as heart, skeletal muscle, liver, and kidney, and that polymorphisms in 
UBL-5 have been linked to obesity and diabetes (Benedetti et al., 2006). 
dve-1 is another gene involved in the UPRmt (Haynes et al., 2007). The DVE-1 protein is a 
putative transcription factor that is localised to the nucleus and possesses a predicted 
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homeobox-related DNA-binding domain. Under mitochondrial stress, DVE-1 exhibits an 
altered nuclear distribution (punctate) and binds to the promoters of the mitochondrial 
chaperone genes hsp-6 and hsp-60. Furthermore, in stressed worms, DVE-1 forms a complex 
with UBL-5. Interestingly, UBL-5 is also able to form a complex with the mammalian 
orthologue of DVE-1, SATB2, but the relevance of the formation of this complex in the 
UPRmt in mammalian cells is unknown (Haynes et al., 2007).  
CLPP-1 is also essential for UPRmt signalling. CLPP-1, the C. elegans orthologue of the 
bacterial ClpP protease, is localised to the mitochondrial matrix. ClpP is the ATP-dependent 
proteolytic subunit (with a cylindrical shape) of a heteromeric complex formed with a 
partner AAA+ ATPase (Ortega et al., 2004). Bacterial ClpP functions in conjunction with two 
partner chaperones, ClpX and ClpA, associated with a wide range of substrates. Moreover, 
an increase in the levels of misfolded proteins enhances the degradation of these substrates. 
ClpX is the only ClpP partner known in eukaryotes, and to date, the substrates of 
mitochondrial ClpP remain unknown. In C. elegans, CLPP-1 is necessary for DVE-1 
activation. Silencing of CLPP-1 by RNAi prevents the redistribution of DVE-1 in the nucleus 
and the transcriptional up-regulation of UBL-5, suggesting an upstream action of CLPP-1 in 
the activation of the UPRmt. Once CLPP-1 is localised to the mitochondria, it is likely that it 
senses the mitochondrial perturbation and mediates the proteolysis signal that is sent to the 
nucleus. Interestingly, CLPP-1–dependent proteolysis is required for the UPRmt as an 
inhibitor of CLPP-1 proteolytic activity abolishes its effect in activating the stress response 
(Haynes et al., 2007). ClpX is also relevant for UPRmt signalling in C. elegans. There are two 
isoforms of ClpX genes in C. elegans, both of which encode proteins homologous to bacterial 
ClpX, and when both genes are silenced, the UPRmt is attenuated. It appears that the 
function of ClpX in the worm is comparable to that in bacteria and mammals (Haynes et al., 
2010). In bacteria, ClpP breaks down proteins into small peptides. Furthermore, studies in 
yeast have shown that mitochondrial peptides can be extruded to the IMS and subsequently 
to the cytosol.  
The mitochondrial transporter responsible for the extrusion of peptides from the 
mitochondrial matrix in yeast is Mdl1p. Interestingly, there are multiple orthologues of 
Mdl1p in C. elegans, and the most evolutionarily conserved of these, HAF-1, plays a role in 
UPRmt signalling as deletion mutations in the haf-1 gene cause an impairment of this 
response. Additionally, HAF-1 seems to be located in the inner mitochondrial membrane, 
which is consistent with its function in transporting cargo from the matrix to the IMS 
(Haynes et al., 2010). Epistasis analysis has placed HAF-1 upstream of ubl-5 transcriptional 
induction, but not of DVE-1 redistribution in the nucleus, which suggests the existence of 
other transcription factors involved in the UPRmt.  
Subsequently, the protein ZC376.7, which includes a C-terminal leucine zipper domain, a 
predicted nuclear localisation sequence, and a nuclear export sequence, was identified. In 
unstressed worms, ZC376.7 is localised diffusely in the cytosol, but following mitochondrial 
stress, it is translocated to the nucleus. ZC376.7 appears to act downstream of HAF-1 and 
CLPP-1 because the nuclear localisation of this transcription factor in stressed worms is 
attenuated by down-regulation of both HAF-1 and CLPP-1 (Haynes et al., 2010). Further 
studies will be required to better understand this signalling mechanism. It is still unclear 
how small peptides can activate UPRmt signalling and influence the subcellular distribution 
of ZC376.7. Is there a cytoplasmic receptor for these small peptides? Is the nature of the 
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peptides important, or rather, is the rate of efflux the most important feature? It is also of 
particular interest to determine the downstream effectors that influence DVE-1 function. 
Many questions remain unanswered, although knowledge on this topic is progressively 
increasing. 
Interestingly, a recent study using C. elegans as a model system demonstrated that the UPRmt 
can be activated in a cell-non-autonomous manner (Durieux et al., 2011). Mitochondrial 
stress caused by down-regulation of a component of the ETC in the nervous system results 
in activation of the UPRmt in the intestine of the animal. However, it appears that UBL-5 is 
not required for UPRmt activation in this cell-non-autonomous manner. It is still not known 
which signal is transmitted from the nervous system to the periphery, and additional 
research will be required to address these questions further (Figure 3). 
 
Fig. 3. Cell-non-autonomous activation of the UPRmt in C. elegans. 
Generation of mitochondrial stress in the central nervous system by depletion of an ETC 
protein subunit results in the activation of the UPRmt in distant tissues, such as the worm 
intestine (transcriptional up-regulation of hsp6 and hsp60 in intestinal cells). The nature of 
the signal transmitted from the brain to the intestine is presently unknown. 
3.2.2 Mammalian cells 
Work by Zhao and colleagues brought to light the existence of an UPRmt (Zhao et al., 2002). 
The expression of a truncated form of the mitochondrial matrix protein ornithine 
transcarbamylase (OTC), which accumulates in an insoluble state in the matrix, results in 
the activation of nuclear genes encoding mitochondrial stress proteins. Upon accumulation 
of OTC in mitochondria, the mitochondrial chaperones Hsp60, Hsp10, and mtDnaJ as well 
as the protease ClpP are up-regulated. In mammalian cells, mtHsp70 is not up-regulated by 
OTC accumulation, which is consistent with its function as a protein transporter across 
membranes, rather than a stress-sensing molecule. The transcription factors CHOP and 
CCAAT/enhancer-binding protein ǃ (C/EBPǃ) form a hetero-dimer and participate in this 
mitochondrial stress response by binding to the promoters of UPRmt-responsive genes. 
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Furthermore, CHOP protein levels are increased by ΔOTC accumulation, indicating that 
Chop itself is a UPRmt-responsive gene. 
Subsequently, an AP-1 element, which is essential for CHOP function in the UPRmt, was 
identified within the Chop promoter. Interestingly, C/EBP (but not C/EBP) also contains an 
AP-1 site. Because c-Jun binds to AP-1 sites, the effect of a MEK inhibitor on the 
phosphorylation state of JNK upon UPRmt induction was tested, and the results suggest that the 
MEK/JNK2 pathway could play a role in UPRmt signalling (Horibe and Hoogenraad, 2007). 
Six novel UPRmt-responsive genes, encoding the mitochondrial proteases YME1L1 and 
MPP, the import component Tim17A, and the enzymes NDUFB2, Endo G and thioredoxin 
2, have recently been identified (Aldridge et al., 2007). In addition to the CHOP recognition 
element, these genes contain two other conserved elements in their promoters: 
mitochondrial unfolded protein response element (MURE) 1 and 2, which are present in 
nine out of the ten genes found to be up-regulated specifically in the UPRmt, with the 
exception of the Hsp60/10 bidirectional promoter. The transcription factors that bind to the 
CHOP element are known (for example, CHOP and C/EBP), but the transcription factors 
that bind to the MURE elements remain elusive. 
3.3 A distinct signalling pathway originating in the mitochondrial inter-membrane 
space  
The ubiquitin–proteasome pathway probably represents the most common process of 
protein quality control within the cell. Conjugation of ubiquitin chains with a substrate is 
important for various physiological functions, from cell signalling to targeting substrates for 
degradation. The proteasome exists in both the nucleus and the cytoplasm and is 
responsible for protein turnover in these cellular compartments. Interestingly, the 
proteasome is also responsible for the degradation of ER proteins because a fraction of the 
proteasome is associated with ER membranes (Kalies et al., 2005). In the ER, misfolded or 
damaged proteins are recognised by chaperones, such as BiP, and transported to the cytosol, 
where the proteasome degrades them. Inhibition of proteasome activity results in 
accumulation of misfolded proteins in the ER. 
Similarly, inhibition of the proteasome also results in accumulation of unfolded proteins in 
the IMS (Radke et al., 2008). Inhibition of either Hsp90 or the proteasome causes proteins to 
accumulate in the mitochondria (Margineantu et al., 2007). 
Endo G is an IMS protein that accumulates in the IMS following proteasome inhibition 
(Radke et al., 2008). Overexpression experiments using either wild-type or a mutant form of 
Endo G have shown that both forms are substrates for ubiquitination, although the mutant 
form is ubiquitinated at a much higher level. The mitochondrial targeting signal is not 
required for conjugation with ubiquitin. These observations are consistent with the existence 
of a protein quality control system in the cytoplasm prior to the import of proteins to the 
mitochondria. Further analyses have shown that upon proteasome inhibition, wild-type 
Endo G is cleaved by HtrA2, while the mutant forms of the protein are not. Elimination of 
mutant Endo G appears to depend on the proteasome pathway.  
A defect in proteasome activity may cause the accumulation of mitochondrial proteins and 
deregulate their activity. HtrA2 seems to be part of a second checkpoint following the action 
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of the proteasome in the cytosol (Radke et al., 2008). Consistent with this, mutations in 
HtrA2 may impair its function and lead to unwanted accumulation of its putative 
substrates. Furthermore, mutant forms of IMS proteins are resistant to HtrA2 degradation, 
and this could augment their deleterious effect and result in mitochondrial collapse.  
The consequences of unfolded protein accumulation in the IMS have not been explored, 
although a recent study by Papa and Germain showed that upon IMS stress, a distinct 
protective pathway is activated (Papa and Germain, 2011). Overexpression of a mutant form 
of the protein Endo G results in the formation of aggregates in the IMS and mitochondrial 
stress. Under these conditions, HtrA2 and proteasome components increase in an oestrogen 
receptor  (ER)–dependent manner. Accumulation of mutant Endo G does not result in the 
up-regulation of CHOP or Endo G, in contrast to what is observed during the UPRmt. Endo 
G accumulation also does not cause increased expression of BiP or BIM, which is a 
characteristic feature of the UPRER. Using a luciferase reporter with oestrogen-responsive 
elements (EREs), it has been observed that the accumulation of various IMS proteins 
activates ERE-containing genes. Additionally, the activation of EREs depends on ER 
phosphorylation and not ER. ER appears to be phosphorylated by AKT, which in turn is 
activated by ROS. ROS overproduction has been reported following mutant Endo G 
overexpression and is inhibited by the anti-oxidant N-acetylcysteine (NAC), suppressing the 
activation of the ERE reporter. Nuclear respiratory factor 1 (NRF1) is a transcription factor 
that activates the expression of genes involved in mitochondrial respiration and can be 
induced by ER activation. IMS stress results in enhanced NRF1 transcription. Furthermore, 
increased levels of HtrA2 have been detected following IMS stress induction, as have 
increases in proteasome activity. 
4. Conclusions 
Neurodegenerative diseases include a vast number of pathologies, all of which involve the 
progressive degeneration of neurons. Many of these diseases are directly linked to the 
ageing process, such as AD and PD (meaning that age is the main, but not the sole, risk 
factor). The underlying mechanisms associated with the neurodegeneration remain 
undetermined. A better understanding of the causes and mechanisms involved in these 
diseases is essential to develop efficient treatments that not only attenuate their symptoms 
but also alter and possibly reverse disease progression. 
Both mitochondrial dysfunction and protein aggregation have been implicated in PD. 
However, little is known about protein aggregation in the mitochondria and its possible 
links to PD. Mitochondria are essential organelles in the eukaryotic cell with a variety of 
functions, including energy production in the form of ATP. Maintenance of a functional ETC 
in the inner mitochondrial membrane is of extreme importance because dysfunction could 
considerably increase the generation of ROS, causing damage to different components of the 
organelle and subsequently the cell. 
The majority of mitochondrial proteins are produced in the cytosol and imported to the 
organelle as precursors. To cross the mitochondrial membranes, these precursors need to be in 
an unfolded state and need to bind to membrane transporters to reach the mitochondrial 
matrix. Mitochondrial chaperones are therefore extremely important in assisting in the folding 
of the newly imported proteins as well as that of newly synthesised proteins in the matrix. 
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Through evolution, mitochondria have gained defence mechanisms against damage. 
Different lines of defence, termed molecular, organellar and cellular quality control, can be 
successively activated to respond to such damage. In this review, we focused on the 
molecular mechanisms of mitochondrial quality control, which rely on the actions of 
chaperones and proteases to maintain a healthy pool of mitochondria. Failure of this 
molecular quality control has been linked to neurodegeneration; it appears that many of the 
proteins involved in this aspect of mitochondrial quality control are associated with PD. For 
example, both PINK1 and HtrA2 have been linked to PD. PINK1 and HtrA2 are part of a 
stress-sensing pathway in which PINK1 facilitates HtrA2 phosphorylation, increasing its 
proteolytic activity and subsequently its protective effect (through a mechanism that is not 
clearly understood). Additionally, PINK1 acts upstream of the chaperone TRAP1, which 
might also be involved in mitochondrial quality control as its protective effect against 
various apoptotic stimuli has been well documented.  
The discovery of an UPRmt is also extremely interesting, and revealing the components and 
mechanisms involved in this stress response may shed light on new strategies for disease 
treatments.  
Up-regulation of chaperones has been proposed for the treatment of a number of 
pathologies, but the results have not always been satisfactory. For example, up-regulation of 
Hsp70 can ameliorate some conditions and increase lifespan in animal models, but it also 
increases tumour development. Understanding the roles of mitochondrial stress modulators 
is therefore essential for the identification of putative targets for drug treatments. 
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